ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Eculizumab Dose Reduction Is Safe by Monitoring Eculizumab Pre-Dose Level and Functional Complement Assays.

    M. Gelens,1 T. Havenith,2 J. Damoiseaux,3 M. Christiaans.1

    1Internal Medicine, MUMC, Maastricht, Netherlands; 2Clinical Pharmacy, MUMC, Maastricht, Netherlands; 3Central Diagnostic Laboratory, MUMC, Maastricht, Netherlands

    Background & aims: Untreated atypical haemolytic syndrome (aHUS) leads to ESRD and may recur after renal transplantation. Eculizumab (Ecu), a humanized antibody inhibiting terminal C5…
  • 2017 American Transplant Congress

    Kidney Insertion Through Vagina and Robotic Assisted Laparoscopic Kidney Transplantation: A Pilot Study.

    P. Modi,1 B. Pal,1 S. Kumar,1 R. Nagarajan,1 V. Kothari,1 M. Modi,2 V. Shah,2 V. Kute,3 H. Patel,3 H. Trivedi.3

    1Transplantation Surgery and Urology, Institute of Kidney Diseases and Research Centre, Ahmedabad, India; 2Anesthesiology, Institute of Kidney Diseases and Research Centre, Ahmedabad, India; 3Nephrology, Institute of Kidney Diseases and Research Centre, Ahmedabad, India

    Minimally invasive kidney transplantation is emerging modality of treatment; both laparoscopic and robotic assisted laparoscopic kidney transplantation are technically feasible and safe. In female recipients,…
  • 2017 American Transplant Congress

    Donor Age > 50 Years and CIT Longer Than 18 Hour Are Independent Risk Factors for One Year Graft Survival in Renal Transplant Form Uncontrolled Donors After Circulatory Death (uDCD).

    M. Molina, E. Gutierrez, E. Gonzalez, E. Morales, J. Cabrera, A. Andres.

    Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Nephrology Department, Hospital Evangelico y Hospital Militar, Montevideo, Uruguay

    Introduction: Kidneys transplantations (KT) from uDCD have higher ischemia injury. It develops in higher primary non-function and delayed graft function, lower graft survival and worst…
  • 2017 American Transplant Congress

    Ethnocultural Barriers to Pre-Emptive Kidney Transplantation: A Single Centre Retrospective Cohort Study.

    A. Bansal, M. Kwok, S. Cao, O. Famure, S. Kim, I. Mucsi.

    University Health Network, Toronto, ON, Canada

    BackgroundPre-emptive kidney transplant (PKT) may offer better outcomes compared to kidney transplant (KT) after starting dialysis. There is a well-documented disparity in access to PKT…
  • 2017 American Transplant Congress

    Sequential Surgical Strategy for Heart-Kidney Transplantation.

    D. Mital,1 M. Petruccione,1 J. Brown,1 S. Vasquez,1 S. Wheaton,1 W. Johnson,1 C. Desai,1 D. Chhabra,1 G. Kinzler,1 H. Sankary,1 T. Lawrecki,1,2 P. Pappas,2 A. Tatooles,2 M. Bresticker,2 W. Cotts,2 G. Bhat.2

    1Kidney Transplant Program, General Surgery, Advocate Christ Medical Center, Oak Lawn, IL; 2Heart Failure and Transplant Program, Advocate Christ Medical Center, Oak Lawn, IL

    Purpose: To describe a unique sequential surgical strategy for heart-kidney transplantation.Methods: We reviewed all 6 patients who received combined heart-kidney transplants at our institution between…
  • 2017 American Transplant Congress

    Reducing the Early Readmission Rates in Kidney Transplantation.

    M. Tavares, M. Cristelli, L. Viana, I. Malbouisson, M. Paula, H. Silva Junior, J. Pestana.

    Nephrology Division, Hospital do Rim Foudation, São Paulo, Brazil

    Background: 30-day hospital readmission rate is a well-accepted quality metric and a predictor of mortality among kidney transplant recipients.Objective: The aim of this study is…
  • 2017 American Transplant Congress

    Scoring of Distinct Tubular Injury Features and Assessment of Cellular Proliferation and of Non-Apoptotic Cell Death by the Novel Marker FACL4 Allow to Determine the Long-Term Prognosis of Renal Grafts.

    A. Bohlmann,1 J. Schmitz,1 A. Melk,1 R. Schmitt,1 I. Scheffner,1 V. Broeker,2 H. Haller,1 J. Metzger,3 J. Braesen,1 W. Gwinner.1

    1Hannover Medical School, Hannover, Germany; 2University of Gothenburg, Gothenburg, Sweden; 3Mosaiques Diagnostics, Hannover, Germany

    Acute tubular injury (ATI) is common in renal grafts and is related to an inferior long-term function. There is no consensus which of the tubular…
  • 2017 American Transplant Congress

    Significance of Atypical Cytology in the Evaluation of Patients with End Stage Renal Disease for Transplantation.

    J. Law, O. Ali, H. Brar, P. Luke, A. Sener.

    Urology, Western University, London, ON, Canada

    INTRODUCTION AND OBJECTIVES: Renal transplantation is the most optimal method of treating patients with end-stage renal disease (ESRD). As part of their routine malignancy screening,…
  • 2017 American Transplant Congress

    Proteins in Preservation Fluid Predict Delayed Graft Function of Kidneys from Donors After Circulatory Death.

    B. van Balkom,1 H. Gremmels,1 L. Ooms,4 R. Toorop,2 F. Dor,5 O. de Jong,1 L. Michielsen,1 G. de Borst,2 W. de Jager,3 A. van Zuilen,1 M. Verhaar.1

    1Nephrology and Hypertension, UMC Utrecht, Utrecht, Netherlands; 2Vascular Surgery, UMC Utrecht, Utrecht, Netherlands; 3Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands; 4Surgery, Erasmus MC, Rotterdam, Netherlands; 5Renal and Transplant Services, Imperial College Healthcare NHS Trust, London, United Kingdom

    Background and objectivesKidney transplantation is the preferred treatment for end-stage kidney disease, and donor kidney shortage urges proper donor-recipient matching. Zero-hour biopsies provide predictive value…
  • 2017 American Transplant Congress

    Renal Function Outcomes by HLA Mismatch in De Novo Kidney Transplant Recipients Receiving Everolimus PlusReduced-Dose Cyclosporine versus Mycophenolate Plus Standard-Dose Cyclosporine: 24-Month Subanalysis of A1202 Study.

    K. Yoshida,1 Y. Watarai,2 K. Nakagawa,3 O. Kamisawa.4

    1Kitasato University, Sagamihara, Japan; 2Nagoya Daini Red Cross Hospital, Nagoya, Japan; 3Ichikawa General Hospital, Tokyo Dental College, Ichikawa, Japan; 4Novartis Pharma K.K., Tokyo, Japan

    Purpose: High levels of human leukocyte antigen (HLA) mismatches are a key determinant of kidney allograft survival. Here, we present 24-month (M) subanalysis of the…
  • « Previous Page
  • 1
  • …
  • 392
  • 393
  • 394
  • 395
  • 396
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences